血管成形术和支架置入术治疗有症状的颅内动脉粥样硬化性疾病：我的方法。
Angioplasty And stenting For symptomatic intracranial atherosclerotic disease: How I Do It.
机构信息
Department of Neuroscience, Valley Baptist Medical Center, Harlingen, TX, USA.
Department of Neurology, School of Medicine, University of Texas Rio Grande Valley, Edinburg, TX, USA.
出版信息
Interv Neuroradiol. 2023 Aug;29(4):459-465. doi: 10.1177/15910199221090430. Epub 2022 Mar 24.
Abstract
Intracranial atherosclerotic disease (ICAD) is a common cause of acute ischemic stroke. ICAD has a high rate of recurrent ischemic stroke despite recommended adequate medical treatment. Endovascular treatment of ICAD has been controversial due to high periprocedural complication in historic randomized clinical trials (RCTs). Recently, a multicenter prospective study of stent placement in patients with high grade intracranial stenosis that evaluated safety and efficacy of Balloon-mounted stents (BMS) in symptomatic ICAD showed low rates of periprocedural stroke (5.6%) than the SAMMPRIS (14.7%) and VISSIT (21.4%) trials. This review highlights the recent evolution of endovascular therapy for symptomatic ICAD.
摘要
颅内动脉粥样硬化性疾病（ICAD）是急性缺血性脑卒中的常见病因。尽管接受了推荐的充分药物治疗，ICAD 仍有很高的复发性缺血性脑卒中发生率。由于历史随机临床试验（RCT）中围手术期并发症发生率较高，ICAD 的血管内治疗一直存在争议。最近，一项对颅内狭窄程度较高的症状性 ICAD 患者进行支架置入的多中心前瞻性研究评估了球囊扩张支架（BMS）的安全性和疗效，结果显示围手术期卒中发生率较低（5.6%），低于 SAMMPRIS（14.7%）和 VISSIT（21.4%）试验。本文综述了症状性 ICAD 的血管内治疗的最新进展。
相似文献
1
Angioplasty And stenting For symptomatic intracranial atherosclerotic disease: How I Do It.血管成形术和支架置入术治疗有症状的颅内动脉粥样硬化性疾病：我的方法。
Interv Neuroradiol. 2023 Aug;29(4):459-465. doi: 10.1177/15910199221090430. Epub 2022 Mar 24.
2
Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study.症状性颅内动脉粥样硬化的次最大血管成形术：一项前瞻性 I 期研究。
J Neurosurg. 2016 Oct;125(4):964-971. doi: 10.3171/2015.8.JNS15791. Epub 2016 Jan 8.
3
Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study.SAMMPRIS 研究后，对于症状性颅内动脉粥样硬化狭窄患者，血管成形术不伴支架置入治疗能否替代支架置入和强化药物治疗预防颅内狭窄患者卒中复发。
Neurosurgery. 2012 Dec;71(6):1103-10. doi: 10.1227/NEU.0b013e318271bcb8.
4
Design of the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) trial in symptomatic intracranial stenosis.Vitesse 颅内支架研究缺血性治疗（VISSIT）试验的设计：症状性颅内狭窄。
J Stroke Cerebrovasc Dis. 2013 Oct;22(7):1131-9. doi: 10.1016/j.jstrokecerebrovasdis.2012.10.021. Epub 2012 Dec 21.
5
Outcomes of tailored angioplasty and/or stenting for symptomatic intracranial atherosclerosis: a prospective cohort study after SAMMPRIS.症状性颅内动脉粥样硬化的个体化血管成形术和/或支架置入术的结局：SAMMPRIS之后的一项前瞻性队列研究
J Neurointerv Surg. 2015 May;7(5):331-5. doi: 10.1136/neurintsurg-2014-011109. Epub 2014 Apr 23.
6
Current Advances in Endovascular Treatment of Intracranial Atherosclerotic Disease and Future Prospective.颅内动脉粥样硬化性疾病血管内治疗的最新进展及未来展望。
J Stroke Cerebrovasc Dis. 2021 Mar;30(3):105556. doi: 10.1016/j.jstrokecerebrovasdis.2020.105556. Epub 2020 Dec 22.
7
Safety and efficacy of balloon-mounted stent in the treatment of symptomatic intracranial atherosclerotic disease: a multicenter experience.球囊载支架治疗症状性颅内动脉粥样硬化性疾病的安全性和有效性：多中心经验。
J Neurointerv Surg. 2022 Aug;14(8):756-761. doi: 10.1136/neurintsurg-2021-017818. Epub 2021 Aug 4.
8
Rescue Intracranial Balloon Angioplasty with or without Stent Placement in Acute Strokes with Intracranial Atherosclerotic Disease.颅内动脉粥样硬化性疾病所致急性脑卒中血管内球囊成形术或支架置入术的血管内开通治疗
World Neurosurg. 2023 Aug;176:e8-e13. doi: 10.1016/j.wneu.2023.01.057. Epub 2023 Jan 18.
9
Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations.支架置入后颅内血管成形术和支架置入与强化药物治疗预防颅内狭窄患者卒中复发（SAMMPRIS）试验：现状与未来思考。
J Neuroimaging. 2012 Jan;22(1):1-13. doi: 10.1111/j.1552-6569.2011.00685.x.
10
Submaximal Angioplasty for Symptomatic Intracranial Atherosclerotic Disease: A Meta-Analysis of Peri-Procedural and Long-Term Risk.症状性颅内动脉粥样硬化疾病的次最大血管成形术：围手术期和长期风险的荟萃分析。
Neurosurgery. 2020 Jun 1;86(6):755-762. doi: 10.1093/neuros/nyz337.
引用本文的文献
1
Evaluation of paclitaxel-coated balloon angioplasty for the treatment of symptomatic intracranial in-stent restenosis.紫杉醇涂层球囊血管成形术治疗有症状的颅内支架内再狭窄的评估。
Front Neurol. 2024 May 22;15:1360609. doi: 10.3389/fneur.2024.1360609. eCollection 2024.
2
The resolute Onyx in TIA management (ROTIA).短暂性脑缺血发作管理中的坚定玛瑙（ROTIA）
Interv Neuroradiol. 2024 Apr 23:15910199241249211. doi: 10.1177/15910199241249211.
3
Assessment of paclitaxel drug-coated balloon angioplasty for intracranial atherosclerotic disease based on high-resolution vessel wall magnetic resonance imaging.基于高分辨率血管壁磁共振成像的紫杉醇药物涂层球囊血管成形术治疗颅内动脉粥样硬化疾病的评估
Interv Neuroradiol. 2024 Mar 27:15910199241239718. doi: 10.1177/15910199241239718.
本文引用的文献
1
Safety and efficacy of balloon-mounted stent in the treatment of symptomatic intracranial atherosclerotic disease: a multicenter experience.球囊载支架治疗症状性颅内动脉粥样硬化性疾病的安全性和有效性：多中心经验。
J Neurointerv Surg. 2022 Aug;14(8):756-761. doi: 10.1136/neurintsurg-2021-017818. Epub 2021 Aug 4.
2
Initial Experience With the Next-Generation Resolute Onyx Zotarolimus-Eluting Stent in Symptomatic Intracranial Atherosclerotic Disease.新一代Resolute Onyx佐他莫司洗脱支架治疗有症状颅内动脉粥样硬化疾病的初步经验
Front Neurol. 2020 Sep 30;11:570100. doi: 10.3389/fneur.2020.570100. eCollection 2020.
3
The WOVEN trial: Wingspan One-year Vascular Events and Neurologic Outcomes.WOVEN 试验：Wingspan 一年血管事件和神经结局。
J Neurointerv Surg. 2021 Apr;13(4):307-310. doi: 10.1136/neurintsurg-2020-016208. Epub 2020 Jun 19.
4
WEAVE Trial: Final Results in 152 On-Label Patients.WEAVE 试验：152 名适应证患者的最终结果。
Stroke. 2019 Apr;50(4):889-894. doi: 10.1161/STROKEAHA.118.023996.
5
Balloon-Mounted versus Self-Expanding Stent Outcomes in Symptomatic Middle Cerebral Artery Stenosis Combined with Poor Collaterals in China: A Multicenter Registry Study.中国症状性大脑中动脉狭窄合并侧支循环不良患者中球囊扩张式支架与自膨式支架的疗效比较：一项多中心注册研究
World Neurosurg. 2019 Apr;124:e675-e681. doi: 10.1016/j.wneu.2018.12.189. Epub 2019 Jan 16.
6
Challenges in the Medical Management of Symptomatic Intracranial Stenosis in an Urban Setting.城市环境中症状性颅内狭窄的医学管理挑战
Stroke. 2017 Aug;48(8):2158-2163. doi: 10.1161/STROKEAHA.116.016254. Epub 2017 Jul 5.
7
Comparison of 3D magnetic resonance imaging and digital subtraction angiography for intracranial artery stenosis.三维磁共振成像与数字减影血管造影在颅内动脉狭窄中的比较。
Eur Radiol. 2017 Nov;27(11):4737-4746. doi: 10.1007/s00330-017-4860-6. Epub 2017 May 12.
8
Clinical interpretation of high-resolution vessel wall MRI of intracranial arterial diseases.颅内动脉疾病高分辨率血管壁磁共振成像的临床解读
Br J Radiol. 2016 Nov;89(1067):20160496. doi: 10.1259/bjr.20160496. Epub 2016 Sep 20.
9
Safety and Efficacy of Wingspan Stenting for Severe Symptomatic Atherosclerotic Stenosis of the Middle Cerebral Artery: Analysis of 278 Continuous Cases.Wingspan支架治疗大脑中动脉重度症状性动脉粥样硬化狭窄的安全性和有效性：278例连续病例分析
J Stroke Cerebrovasc Dis. 2016 Oct;25(10):2368-72. doi: 10.1016/j.jstrokecerebrovasdis.2016.05.035. Epub 2016 Jun 17.
10
Multicenter Prospective Trial of Stent Placement in Patients with Symptomatic High-Grade Intracranial Stenosis.症状性颅内重度狭窄患者支架置入的多中心前瞻性试验
AJNR Am J Neuroradiol. 2016 Jul;37(7):1275-80. doi: 10.3174/ajnr.A4698. Epub 2016 Feb 11.
Zotero 插件